Aschenbach LC - Search Results

1

Prostaglandin E2 receptors are differentially expressed in subpopulations of granulosa cells from primate periovulatory follicles.

Harris SM, Aschenbach LC, Skinner SM, Dozier BL, Duffy DM. Harris SM, et al. Among authors: aschenbach lc. Biol Reprod. 2011 Nov;85(5):916-23. doi: 10.1095/biolreprod.111.091306. Epub 2011 Jul 13. Biol Reprod. 2011. PMID: 21753194 Free PMC article.

2

The LIF receptor antagonist PEGLA is effectively delivered to the uterine endometrium and blocks LIF activity in cynomolgus monkeys.

Aschenbach LC, Hester KE, McCann NC, Zhang JG, Dimitriadis E, Duffy DM. Aschenbach LC, et al. Contraception. 2013 Jun;87(6):813-23. doi: 10.1016/j.contraception.2012.09.032. Epub 2012 Oct 31. Contraception. 2013. PMID: 23121824

3

14-O-Heterocyclic-substituted naltrexone derivatives as non-peptide mu opioid receptor selective antagonists: design, synthesis, and biological studies.

Li G, Aschenbach LC, He H, Selley DE, Zhang Y. Li G, et al. Among authors: aschenbach lc. Bioorg Med Chem Lett. 2009 Mar 15;19(6):1825-9. doi: 10.1016/j.bmcl.2008.12.093. Epub 2008 Dec 29. Bioorg Med Chem Lett. 2009. PMID: 19217280 Free PMC article.

4

Design, synthesis, and biological evaluation of 14-heteroaromatic-substituted naltrexone derivatives: pharmacological profile switch from mu opioid receptor selectivity to mu/kappa opioid receptor dual selectivity.

Yuan Y, Zaidi SA, Elbegdorj O, Aschenbach LC, Li G, Stevens DL, Scoggins KL, Dewey WL, Selley DE, Zhang Y. Yuan Y, et al. Among authors: aschenbach lc. J Med Chem. 2013 Nov 27;56(22):9156-69. doi: 10.1021/jm4012214. Epub 2013 Nov 7. J Med Chem. 2013. PMID: 24144240 Free PMC article.

5

Design, synthesis, and biological evaluation of 6alpha- and 6beta-N-heterocyclic substituted naltrexamine derivatives as mu opioid receptor selective antagonists.

Li G, Aschenbach LC, Chen J, Cassidy MP, Stevens DL, Gabra BH, Selley DE, Dewey WL, Westkaemper RB, Zhang Y. Li G, et al. Among authors: aschenbach lc. J Med Chem. 2009 Mar 12;52(5):1416-27. doi: 10.1021/jm801272c. J Med Chem. 2009. PMID: 19199782 Free PMC article.

6

Synthesis, structural reassignment, and biological activity of type B MAO inhibitors based on the 5H-indeno[1,2-c]pyridazin-5-one core.

Frédérick R, Dumont W, Ooms F, Aschenbach L, Van der Schyf CJ, Castagnoli N, Wouters J, Krief A. Frédérick R, et al. J Med Chem. 2006 Jun 15;49(12):3743-7. doi: 10.1021/jm051091j. J Med Chem. 2006. PMID: 16759116

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6 results

Search Page